EQS-News: CEVEC Pharmaceuticals GmbH / Key word(s): Agreement CEVEC Pharmaceuticals GmbH: ROKOTE Laboratories licenses CEVEC’s CAP® Ad Technology for vaccine manufacturing 20.09.2022 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. ROKOTE Laboratories licen.
DGAP-News: CEVEC Pharmaceuticals GmbH / Key word(s): Miscellaneous CEVEC's license partner RZNOMICS Inc. receives approval to initiate clinical development of CAP Ad Technology-produced gene
DGAP-News: CEVEC Pharmaceuticals GmbH / Key word(s): Miscellaneous CEVEC’s license partner RZNOMICS Inc. receives approval to initiate clinical development of CAP® Ad Technology-produced gene therapy vector in liver cancer patients 13.07.2022 / 14:00 The issuer is solely responsible for the cont.
Issuer: 4TEEN4 Pharmaceuticals GmbH / Key word(s): Study 11.04.2022 / 11:00 The issuer is solely responsible for the content of this announcement. Dipeptidyl Peptidase 3 release is